Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 49

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 49
---
 parties. In addition, some
countries limit the enforceability of patents against third parties, including government agencies or government contractors. In these
countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a country-by-country basis, which
is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain
countries, and we will not have the benefit of patent protection in such countries.

Proceedings to enforce our
patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our
business. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. In addition, changes
in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection
for our technology and the enforcement of our intellectual property.

<div align='center'>33</div>

We may be subject to claims that we or our employees have misappropriated the intellectual property of a third party, including trade secrets or know-how, or are in breach of non-competition or non-solicitation agreements with our competitors and third parties may claim an ownership interest in intellectual property we regard as our own.

Many of our employees and
consultants were previously employed at or engaged by other medical device companies, including our competitors or potential competitors.
Some of these employees, consultants and contractors may have executed proprietary rights, non-disclosure and non-competition agreements
in connection with such previous employment. Although we try to ensure that our employees and consultants do not use the intellectual
property, proprietary information, know-how or trade secrets of others in their work for us, we may be subject to claims that we or these
individuals have, inadvertently or otherwise, misappropriated the intellectual property or disclosed the alleged trade secrets or other
proprietary information, of these former employers, competitors or other third parties. Additionally, we may be subject to claims from
third parties challenging our ownership interest in or inventorship of intellectual property we regard as our own, for example, based
on claims that our agreements with employees or consultants obligating them to assign intellectual property to us are ineffective or in
conflict with prior or competing contractual obligations to assign inventions to another employer, to a former employer, or to another
person or entity. Litigation may be necessary to defend against claims, and it may be necessary or we may desire to enter into a license
to settle any such claim; however,